- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03624335
Influence of Umbilical Cord Clamping Time in the Newborn
Influence of Umbilical Cord Clamping Time in the Newborn, Secondary Neonatal Morbidity and Iron Deposits in the Neonate
Study Overview
Status
Detailed Description
It is an intervention study without drugs administration with a longitudinal, prospective comparison and correlational design.
Patients are recruited by simple random sampling to one of the two intervention groups:
Group 1-ECC: Early clamping of the umbilical cord (before the first minute of life).
Group 2-DCC: Delayed clamping of the umbilical cord (when it stops beating).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Castellón
-
Villarreal, Castellón, Spain, 12540
- Hospital Universitario de La Plana
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- neonates with a gestational age of 35 to 42 weeks and born through normal vaginal delivery.
Exclusion Criteria:
- monochorionic multiples
- incarcerated mothers
- placenta previa
- concern for abruptions
- Rh sensitization
- hydrops
- congenital anomalies
- the obstetrician declining to perform the intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1: ECC
In the ECC group, the cord was clamped immediately after delivery, before the first minute of life. Blood test 6hours after clamping Blood test 24hours after clamping Blood test 48hours after clamping Blood test 28days after clamping |
Early clamping of the umbilical cord
Blood Test 6hours
Blood Test 24hours
Blood Test 48hours
Blood Test 28days
|
Experimental: Group 2: DCC
In the DCC group, the cord was clamped when it stops beating.
Blood test 6hours after clamping Blood test 24hours after clamping Blood test 48hours after clamping Blood test 28days after clamping
|
Blood Test 6hours
Blood Test 24hours
Blood Test 48hours
Blood Test 28days
Delayed clamping of the umbilical cord
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
haemoglobin
Time Frame: 6hours
|
haemoglobin level
|
6hours
|
haemoglobin
Time Frame: 28 days
|
haemoglobin level
|
28 days
|
haematocrit
Time Frame: 6 hours
|
haematocrit level
|
6 hours
|
haematocrit
Time Frame: 28 days
|
haematocrit level
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
serum ferritin
Time Frame: 6hours
|
serum ferritin level
|
6hours
|
serum ferritin
Time Frame: 28days
|
serum ferritin level
|
28days
|
bilirubin
Time Frame: 6hours
|
bilirubin level
|
6hours
|
bilirubin
Time Frame: 28days
|
bilirubin level
|
28days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Vanesa Rodenas, PhD, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CORD STUDY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperbilirubinemia, Neonatal
-
University of AarhusCompletedUncomplicated Neonatal HyperbilirubinemiaDenmark
-
Guangzhou Women and Children's Medical CenterRecruitingNeonatal Hyperbilirubinemia | Neonatal Jaundice | Hemolysis NeonatalChina
-
HonorHealth Research InstituteNeolightCompletedNeonatal Hyperbilirubinemia | Jaundice, Neonatal | Neonatal DisorderUnited States
-
National Liver Institute, EgyptCompleted
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingNeonatal HyperbilirubinemiaChina
-
Region Örebro CountyCompleted
-
University of PatrasCompleted
-
Erebouni Medical CenterRecruitingNeonatal Hyperbilirubinemia | Jaundice, NeonatalArmenia
-
Hacettepe UniversityCompletedHyperbilirubinemia, Neonatal IndirectTurkey
-
University of OxfordCompletedNeonatal HyperbilirubinemiaThailand
Clinical Trials on ECC
-
Johann Wolfgang Goethe University HospitalCompletedExercise Induced Asthma | Exercise Induced Pharyngeal CollapseGermany
-
Sahlgrenska University Hospital, SwedenSuspendedDiabetes Mellitus, Kidney, CPBSweden
-
University Hospital TuebingenCompleted
-
Catharina Ziekenhuis EindhovenCompletedThrombocytopathyNetherlands
-
AdministrateurCICCompleted
-
Hadassah Medical OrganizationUnknown
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingAnterior Cruciate Ligament InjuryUnited States
-
Rigshospitalet, DenmarkLundbeck FoundationCompleted
-
University Hospital, ToulousePfizer; Roche Pharma AG; Federation Francophone de Cancerologie DigestiveCompleted
-
XVIVO PerfusionTerminatedAcute Kidney Injury | Extracorporeal Circulation; Complications | Cardiac Surgical ProceduresSweden